NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Toll Brothers Q4 Earnings: Revenue Up But Cautious 2026 Outlook Sends Shares Lower

Toll Brothers (TOL) reports mixed Q4 results with revenue beating estimates but lower fiscal 2026 delivery guidance amid soft housing demand and market uncertainty.

Toll Brothers Q4 Earnings: Revenue Up But Cautious 2026 Outlook Sends Shares Lower
Credit: Toll Brothers
Already have an account? Sign in.
12/09/2025 · 6:35 AM
TOL
/ Read more

Feed↓

Assertio Shares Jump as Garda Raises All-Cash Buyout Offer to $21.80 Per Share ($153M Deal)
05/04/2026 · 9:34 AM

Assertio Shares Jump as Garda Raises All-Cash Buyout Offer to $21.80 Per Share ($153M Deal)

Garda raised bid to $21.80/share cash to buy Assertio, boosting stock ~17%. Deal gives shareholders higher, certain payout.

/ Subscriber only
Eli Lilly Stock Falls on Foundayo Liver Report
Featured/ 05/04/2026 · 9:02 AM

Eli Lilly Stock Falls on Foundayo Liver Report

Lilly stock dropped after a single liver issue report tied to its new weight-loss pill Foundayo, but the evidence is weak and likely an overreaction.

/ Subscriber only
FDA Gives Green Light: Clene’s New ALS Drug Moves Closer to Faster Approval
05/04/2026 · 8:41 AM

FDA Gives Green Light: Clene’s New ALS Drug Moves Closer to Faster Approval

FDA may fast-track Clene’s ALS drug CNM-Au8 after strong results, offering hope for longer life and slower disease progression.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe